Invention Grant
- Patent Title: Penicillin-binding protein inhibitors
-
Application No.: US16616294Application Date: 2018-05-25
-
Publication No.: US11332485B2Publication Date: 2022-05-17
- Inventor: Christopher J. Burns , Denis Daigle , Guo-Hua Chu , Jodie Hamrick , Matthew Lucas , Steven A. Boyd , Allison L. Zulli , Eugen F. Mesaros , Stephen M. Condon , Robert E. Lee Trout , Cullen L. Myers
- Applicant: VenatoRx Pharmaceuticals, Inc.
- Applicant Address: US PA Malvern
- Assignee: VenatoRx Pharmaceuticals, Inc.
- Current Assignee: VenatoRx Pharmaceuticals, Inc.
- Current Assignee Address: US PA Malvern
- Agency: Wilson Sonsini Goodrich & Rosati
- International Application: PCT/US2018/034722 WO 20180525
- International Announcement: WO2018/218190 WO 20181129
- Main IPC: C07F5/02
- IPC: C07F5/02 ; A61P31/04 ; A61K9/20 ; A61K9/48

Abstract:
Described herein are certain boron-containing compounds, compositions, preparations and their use as modulators of the transpeptidase function of bacterial penicillin-binding proteins and as antibacterial agents. In some embodiments, the compounds described herein inhibit penicillin-binding proteins. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
Public/Granted literature
- US20200157123A1 PENICILLIN-BINDING PROTEIN INHIBITORS Public/Granted day:2020-05-21
Information query